Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOW3-Hydroxyphenylacetic acid is a phenolic acid with diverse biological activities.1,2,3,4 It is formed via microbial metabolism of polyphenolic compounds, including the flavonoid quercetin (Item No. 10005169), by gut microbiota.5 3-Hydroxyphenylacetic acid binds to the γ-hydroxybutyrate receptor (GHBR; IC50 = 12 µM) and GABAA receptors in rat cerebrocortical membranes.1 It increases the activity of aldehyde dehydrogenase (ALDH) in Hepa-1c1c7 and HepG2 cells and protects Hepa-1c1c7 cells from acetaldehyde-induced cytotoxicity when used at a concentration of 10 µM.2 3-Hydroxyphenylacetic acid is active against P. aeruginosa (MIC = 2.1 mg/ml).3 It induces ataxia and decreases locomotor activity in mice (ED50s = 1,677.3 and 1,441.3 mg/kg, respectively), as well as decreases systolic and diastolic blood pressure in spontaneously hypertensive rats when administered at doses ranging from 0.1 to 10 mg/kg.1,4
WARNING This product is not for human or veterinary use.
1. Novel gamma-
2. A major intestinal catabolite of quercetin glycosides, 3-
3. Pseudomonas aeruginosa presents multiple vital changes in its proteome in the presence of 3-
4. 3-
5. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch. Pharm. Res. 21(1), 17-23 (1998).